These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33605851)

  • 1. DL-SMILES#: A Novel Encoding Scheme for Predicting Compound Protein Affinity Using Deep Learning.
    Wang S; Liu J; Ding M; Gao Y; Liu D; Tian Q; Zhu J
    Comb Chem High Throughput Screen; 2022; 25(4):642-650. PubMed ID: 33605851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSGraphCPI: A Novel Model for Predicting Compound-Protein Interactions Based on Deep Learning.
    Wang X; Liu J; Zhang C; Wang S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convolutional neural network based on SMILES representation of compounds for detecting chemical motif.
    Hirohara M; Saito Y; Koda Y; Sato K; Sakakibara Y
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):526. PubMed ID: 30598075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Molecular Representation Learning for Molecular Property Prediction with a Multiple SMILES-Based Augmentation.
    Li C; Feng J; Liu S; Yao J
    Comput Intell Neurosci; 2022; 2022():8464452. PubMed ID: 35178082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AttentionDTA: Drug-Target Binding Affinity Prediction by Sequence-Based Deep Learning With Attention Mechanism.
    Zhao Q; Duan G; Yang M; Cheng Z; Li Y; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(2):852-863. PubMed ID: 35471889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DeepAffinity: interpretable deep learning of compound-protein affinity through unified recurrent and convolutional neural networks.
    Karimi M; Wu D; Wang Z; Shen Y
    Bioinformatics; 2019 Sep; 35(18):3329-3338. PubMed ID: 30768156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug protein interactions based on variable scale characteristic pyramid convolution network.
    Chen Y; Zhu Y; Zhang Z; Wang J; Wang C
    Methods; 2023 Mar; 211():42-47. PubMed ID: 36804213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning to SMILES: BAN-based strategies to improve latent representation learning from molecules.
    Wu CK; Zhang XC; Yang ZJ; Lu AP; Hou TJ; Cao DS
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34427296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep learning for retention time prediction in reversed-phase liquid chromatography.
    Fedorova ES; Matyushin DD; Plyushchenko IV; Stavrianidi AN; Buryak AK
    J Chromatogr A; 2022 Feb; 1664():462792. PubMed ID: 34999303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BACPI: a bi-directional attention neural network for compound-protein interaction and binding affinity prediction.
    Li M; Lu Z; Wu Y; Li Y
    Bioinformatics; 2022 Mar; 38(7):1995-2002. PubMed ID: 35043942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The power of deep learning to ligand-based novel drug discovery.
    Baskin II
    Expert Opin Drug Discov; 2020 Jul; 15(7):755-764. PubMed ID: 32228116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ELECTRA-DTA: a new compound-protein binding affinity prediction model based on the contextualized sequence encoding.
    Wang J; Wen N; Wang C; Zhao L; Cheng L
    J Cheminform; 2022 Mar; 14(1):14. PubMed ID: 35292100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De Novo Molecule Design by Translating from Reduced Graphs to SMILES.
    Pogány P; Arad N; Genway S; Pickett SD
    J Chem Inf Model; 2019 Mar; 59(3):1136-1146. PubMed ID: 30525594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Explainable Anticancer Compound Sensitivity Prediction via Multimodal Attention-Based Convolutional Encoders.
    Manica M; Oskooei A; Born J; Subramanian V; Sáez-Rodríguez J; Rodríguez Martínez M
    Mol Pharm; 2019 Dec; 16(12):4797-4806. PubMed ID: 31618586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Target Interaction Prediction: End-to-End Deep Learning Approach.
    Monteiro NRC; Ribeiro B; Arrais JP
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2364-2374. PubMed ID: 32142454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeepFusion: A deep learning based multi-scale feature fusion method for predicting drug-target interactions.
    Song T; Zhang X; Ding M; Rodriguez-Paton A; Wang S; Wang G
    Methods; 2022 Aug; 204():269-277. PubMed ID: 35219861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STOUT: SMILES to IUPAC names using neural machine translation.
    Rajan K; Zielesny A; Steinbeck C
    J Cheminform; 2021 Apr; 13(1):34. PubMed ID: 33906675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Drug-Target Affinity Based on Recurrent Neural Networks and Graph Convolutional Neural Networks.
    Tian Q; Ding M; Yang H; Yue C; Zhong Y; Du Z; Liu D; Liu J; Deng Y
    Comb Chem High Throughput Screen; 2022; 25(4):634-641. PubMed ID: 33588722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Learning-Based Modeling of Drug-Target Interaction Prediction Incorporating Binding Site Information of Proteins.
    D'Souza S; Prema KV; Balaji S; Shah R
    Interdiscip Sci; 2023 Jun; 15(2):306-315. PubMed ID: 36967455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.